|

Pemetrexed Disodium Clinical Trials

2 actively recruiting trials across 1 location

Also known as: Alimta, Almita, LY231514, N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid Disodium Salt

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Shanghai Chest Hospital1
  • National Cancer Institute (NCI)1

Indications

  • Lung Cancer2
  • Cancer2
  • Lung Non-Squamous Non-Small Cell Carcinoma1
  • Lung Non-Small Cell Squamous Carcinoma1
  • Lung Cancer - Non Small Cell1

Other1 trial

Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer
Phase 2

Anchorage, Alaska1 trial

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Anchorage Associates in Radiation Medicine

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.